A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2004
12/15/2004	CN1554439A Medicinal composition for treating pain
12/15/2004	CN1554435A Specific rheumatic medicinal wine and its preparing method
12/15/2004	CN1554404A Recovery paste for osteonosus
12/15/2004	CN1554395A Chinese medicinal composition for treating rheumatoid arthritis
12/15/2004	CN1554374A Method for producing hyperplasia and traumatic injury paste
12/15/2004	CN1554369A Medicine for treating rheumatoid arthritis and its preparing method
12/15/2004	CN1554368A Medicinal composition for treating rheumatism
12/15/2004	CN1554348A Method for preparing slow release micro pill of aspirin
12/15/2004	CN1179970C Purine derivatives
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179960C Indole derivatives and their use for treamtent of osteoporosis amongst other applications
12/15/2004	CN1179958C Cyclic substituted aminomethyl compounds and medicaments containing said compounds
12/15/2004	CN1179954C Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg. them
12/15/2004	CN1179952C Pyrimidine-4-one derivatives as LDL-PLA2 inhibitors
12/15/2004	CN1179744C Ointment having pain-killing relieving itching, removing toxic substances and promoting granulation function
12/15/2004	CN1179737C Chinese medicine for curing rheumatoid disease
12/15/2004	CN1179735C Litholytic medicine for treating hepatolith and preparation process thereof
12/14/2004	US6831186 Antiinflammatory agents; autoimmune disease
12/14/2004	US6831178 Crystal structure; stability; bioavailability
12/14/2004	US6831106 Vitamin D analogues
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6831101 Compounds that bind to one or more RANTES receptors for treatment of chemokine mediated disease states
12/14/2004	US6831097 2,3-diaryl-pyrazolo[1,5-B]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
12/14/2004	US6831093 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
12/14/2004	US6831091 Anticancer agents
12/14/2004	US6831085 Methods and compositions utilizing quinazolinones
12/14/2004	US6831075 Heterocyclic substituted pyrazolones
12/14/2004	US6831069 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
12/14/2004	US6831065 Anti-inflammatory compounds and uses thereof
12/14/2004	US6830893 T20/DP178 is an activator of human phagocyte formyl peptide receptors
12/14/2004	US6830750 Reduction of oxidative stress factors with Lactobacillus plantarum
12/14/2004	CA2284278C Histone containing composition to treat rheumatoid arthritis
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/14/2004	CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/09/2004	WO2004106938A2 Diagnostics and therapeutics for diseases associated with g protein-coupled p2y purinoreceptor 7 (p2y7)
12/09/2004	WO2004106934A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
12/09/2004	WO2004106342A1 (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane is an effective analgesic agent
12/09/2004	WO2004106321A1 4-aryl-5h-thiophene-2-one derivatives and its preparation and use
12/09/2004	WO2004106317A1 Benzofuran compound and medicinal composition containing the same
12/09/2004	WO2004106312A1 Novel 2-aminoselenazoline derivative and use thereof
12/09/2004	WO2004106292A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith
12/09/2004	WO2004106289A1 Protease inhibitors
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	WO2004105798A1 A PHARMACEUTICAL COMPOSITION COMPRISING A P2X7-RECEPTOR ANTAGONIST AND A TUMOUR NECROSIS FACTOR α
12/09/2004	WO2004105797A1 A pharmaceutical composition comprising a p2x7 antagonist and sulfasalazine
12/09/2004	WO2004105796A1 A pharmaceutical composition containing a p2x7 receptor antagonist and methotrexate
12/09/2004	WO2004105785A2 Use of pam
12/09/2004	WO2004105773A2 Use of s1p
12/09/2004	WO2004105678A2 Pharmaceutical composition based on ketorolac or one of its salts pharmaceutically acceptable and use of ketorolac or its salts in pharmaceutical compositions
12/09/2004	WO2004087699A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004	WO2004087698A3 Thiazoles useful as inhibitors of protein kinases
12/09/2004	WO2004087119A3 Compositions containing superoxide dismutase and a selected et 5-lipoxygenase inhibitor and uses thereof
12/09/2004	WO2004066925B1 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
12/09/2004	WO2004058275A3 Compositions of magnetic particles covered with gem-bisphosphonate derivatives
12/09/2004	WO2003097082A3 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
12/09/2004	WO2003053219A3 Methods for slowing senescence and treating and preventing diseases associated with senescence
12/09/2004	US20040249161 Biphenyl-derivatives as p38-kinase inhibitors
12/09/2004	US20040249153 For therapy of inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis and tumors
12/09/2004	US20040249132 Nuclear hormone receptor ligand binding domain
12/09/2004	US20040249125 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
12/09/2004	US20040249123 Nuclear receptor for use in identifying modulator for diagnosis, prevention and treatment of cell proliferative, blood, cardiovascular, skin, inflammatory, bone and nervous system disorders
12/09/2004	US20040248978 Synergistic pain treatment, side effect reduction; a mixture of pregabalin or tiagabine and 2-[4-(2-fluorobenzyloxy) benzylamino] propanamide
12/09/2004	US20040248974 Self emulsifying drug delivery system
12/09/2004	US20040248966 A drug contains melatonin, other melatonergic agents, melatonin agonists and melatonin antagonists, in an effective amount within the range of 0.0025 to 50 mg, and other therapeutic agent; improving the restorative quality of sleep; sustained release
12/09/2004	US20040248964 Analgesic uses of norketamine and ketamine/norketamine prodrugs
12/09/2004	US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004	US20040248936 such as (R)-1-{4-[4-(4-Phenoxy-2-propyl-phenoxy)-butoxy]-benzenesulfonyl}-azetidine-2-carboxylic acid, used as peroxisome proliferator-activated receptor agonists; hypoglycemic agents
12/09/2004	US20040248923 Novel 4-anilinoquinoline-3-carboxamides
12/09/2004	US20040248920 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/09/2004	US20040248919 Insulin sensitizers which do not increase triglyceride levels or suppress thyroid hormone axis; such as 7-[3,5-di-tert-butyl-2-(2,2-difluoroethoxy)-phenyl]-4-fluoro-3-methyl-octa-2,4,6-trienoic acid; synthesis; retinoid X receptor (rxr)
12/09/2004	US20040248916 Pyrimidine derivatives as selective inhibitors of cox-2
12/09/2004	US20040248913 (Pyridinyl and pyrimidyl) trienoic acid derivatives as retinoid x receptor modulators
12/09/2004	US20040248897 Substituted N-acylaniline derivatives, the preparation thereof, and their use as pharmaceutical compositions
12/09/2004	US20040248889 Analgesics; synthesis
12/09/2004	US20040248886 Neuronal disorders, autoimmune diseases, cancer, cardiovascular diseases; such as 4-Chloro-N-{5-[1-(4-trifluoromethyl-benzyl)-piperidin-3-ylsulfamoyl]-25 thiophen-2-ylmethyl)-benzamide
12/09/2004	US20040248885 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
12/09/2004	US20040248867 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives
12/09/2004	US20040248821 Administering bioflavoids with bromelin ; synergistic mixture
12/09/2004	US20040248820 Administering 2-phthalimidoglutaric acid; vision defects; antitumor agents; anticancer agents
12/09/2004	US20040248813 Compounds and methods for the modulation of cd154
12/09/2004	US20040248810 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
12/09/2004	US20040248767 Modulating serum amyloid a interaction with tanis and agents useful for same
12/09/2004	US20040248765 Tumour targeting prodrugs activated by metallo matrixproteinases
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248321 Membrane protein for use in treatment and prevention of inflammatory, circulatory, cell proliferative, metabolic and immunological disorders
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248243 Lipid metabolizing polypeptide for use in identifying modulators for treatment and prevention of cancer, nervous system, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders
12/09/2004	US20040248208 Screening method
12/09/2004	US20040248207 Sodium channel regulators and modulators
12/09/2004	US20040248188 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/09/2004	US20040247676 The active and barrier layers each contain two or more hydrophilic polymers, a lipophilic substance, and an adjuvant; side effect reduction; single daily dosage
12/09/2004	US20040247643 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
12/09/2004	US20040247627 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent
12/09/2004	US20040247604 Anti-inflamatory fatty alcohols and fatty acid esters useful as antigen carriers
12/09/2004	US20040247598 In particular of delayed-type hypersensitivity; especially administering an IL-18 binding protein or a derivative, an expression vector or a genetically engineered cell, optionally with an antiinflammatory agent such as a COX-inhibitor.
12/09/2004	US20040247597 Method of treating atherosclerosis and other inflammatory diseases
12/09/2004	CA2809131A1 Use of s1p
12/09/2004	CA2568609A1 Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith

1 ... 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 ... 1272